BR112018075017A2 - partículas de nicotina - Google Patents

partículas de nicotina

Info

Publication number
BR112018075017A2
BR112018075017A2 BR112018075017-4A BR112018075017A BR112018075017A2 BR 112018075017 A2 BR112018075017 A2 BR 112018075017A2 BR 112018075017 A BR112018075017 A BR 112018075017A BR 112018075017 A2 BR112018075017 A2 BR 112018075017A2
Authority
BR
Brazil
Prior art keywords
particles
nicotine particles
liquid mixture
nicotine
pluralities
Prior art date
Application number
BR112018075017-4A
Other languages
English (en)
Inventor
VOLPE Nicolo
Original Assignee
Philip Morris Products S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philip Morris Products S.A. filed Critical Philip Morris Products S.A.
Publication of BR112018075017A2 publication Critical patent/BR112018075017A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Addiction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

a presente invenção refere-se a um método que inclui a combinar nicotina com um carreador líquido para formar uma mistura líquida e secar por pulverização a mistura líquida para formar uma primeira pluralidade de partículas. as primeiras pluralidades de partículas são então moídas para formar uma segunda pluralidade de partículas.
BR112018075017-4A 2016-06-30 2017-06-21 partículas de nicotina BR112018075017A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16177156 2016-06-30
EP16177156.3 2016-06-30
PCT/IB2017/053710 WO2018002779A1 (en) 2016-06-30 2017-06-21 Nicotine particles

Publications (1)

Publication Number Publication Date
BR112018075017A2 true BR112018075017A2 (pt) 2019-03-19

Family

ID=56296658

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018075017-4A BR112018075017A2 (pt) 2016-06-30 2017-06-21 partículas de nicotina

Country Status (16)

Country Link
US (2) US11458093B2 (pt)
EP (1) EP3478265A1 (pt)
JP (2) JP7471774B2 (pt)
KR (1) KR102559152B1 (pt)
CN (1) CN109310623B (pt)
AU (1) AU2017290610A1 (pt)
BR (1) BR112018075017A2 (pt)
CA (1) CA3023626A1 (pt)
IL (1) IL263340A (pt)
MX (1) MX2018015119A (pt)
PH (1) PH12018502715A1 (pt)
RU (1) RU2741309C2 (pt)
SG (1) SG11201809630RA (pt)
UA (1) UA126853C2 (pt)
WO (1) WO2018002779A1 (pt)
ZA (1) ZA201807080B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190133940A1 (en) * 2016-06-30 2019-05-09 Philip Morris Products S.A. Nicotine particles and compositions
MX2019010263A (es) * 2017-03-07 2019-10-09 Philip Morris Products Sa Formulaciones de nicotina inhalables y metodos de fabricacion y uso de las mismas.
MX2022005510A (es) * 2019-11-14 2022-06-08 Philip Morris Products Sa Formulacion mejorada de polvo seco saborizada con tabaco.
BR112022022858A2 (pt) * 2020-06-15 2022-12-20 Philip Morris Products Sa Composições de anatabina em pó
JP2023540985A (ja) * 2020-09-03 2023-09-27 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム 噴霧乾燥低吸湿性活性粉末組成物
US20220313678A1 (en) * 2021-04-06 2022-10-06 Altria Client Services Llc Spray dried nicotine for inclusion in oral products
WO2024090892A1 (ko) * 2022-10-27 2024-05-02 주식회사 케이티앤지 흡입용 니코틴 건조 분말의 제조 방법
WO2024090890A1 (ko) * 2022-10-27 2024-05-02 주식회사 케이티앤지 흡입용 저용량 니코틴 건조 분말 조성물

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4655231A (en) 1984-01-09 1987-04-07 Advanced Tobacco Products, Inc. Snuff and preparation thereof
JP3388896B2 (ja) * 1994-08-08 2003-03-24 株式会社日立ユニシアオートモティブ 吸入式投薬器
GB9515182D0 (en) 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
CA2231968A1 (en) * 1998-03-11 1999-09-11 Smoke-Stop, A Partnership Consisting Of Art Slutsky Method of producing a nicotine medicament
US20120042886A1 (en) 1998-03-11 2012-02-23 Hanna Piskorz Method of producing a nicotine medicament and a medicament made by the method
US20080138398A1 (en) 1999-07-16 2008-06-12 Aradigm Corporation Dual release nicotine formulations, and systems and methods for their use
US6799576B2 (en) 1999-07-16 2004-10-05 Aradigm Corporation System for effecting smoking cessation
US8256433B2 (en) 1999-07-16 2012-09-04 Aradigm Corporation Systems and methods for effecting cessation of tobacco use
US6586008B1 (en) * 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
US6962006B2 (en) * 2002-12-19 2005-11-08 Acusphere, Inc. Methods and apparatus for making particles using spray dryer and in-line jet mill
GB0425758D0 (en) 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
ITMI20051999A1 (it) * 2005-10-21 2007-04-22 Eratech S R L Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'
FI20060428L (fi) 2006-05-03 2007-11-04 Esko Kauppinen Pintamodifioidut aerosolihiukkaset, menetelmä ja laite niiden tuottamiseksi sekä jauheet ja dispersiot jotka sisältävät kyseisiä hiukkasia
WO2010060875A1 (de) 2008-11-27 2010-06-03 Boehringer Ingelheim International Gmbh Neue pulverförmige kristalline arzneimittel zur inhalation
CA2763939A1 (en) 2009-05-29 2010-12-02 Pearl Therapeutics, Inc. Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting b2 adrenergic receptor agonists and associated methods and systems
WO2013130767A1 (en) 2012-02-29 2013-09-06 Pulmatrix, Inc. Inhalable dry powders
SE536491C2 (sv) 2012-03-26 2013-12-27 Bionicotine Ab Påse innehållande nikotin och en tuggummikomposition
US20140261474A1 (en) 2013-03-15 2014-09-18 Aradigm Corporation Methods for inhalation of smoke-free nicotine
ITMI20130572A1 (it) 2013-04-10 2014-10-11 Eratech Srl Composizione comprendente almeno due polveri secche ottenute per spray dry per aumentare la stabilita' della formulazione
EP2993999B1 (en) 2013-05-06 2021-01-27 Juul Labs, Inc. Nicotine salt formulations for electronic cigarettes and method of delivering nicotine
CN105828819A (zh) * 2014-04-08 2016-08-03 桑萨（巴巴多斯）公司 烟碱制剂及其制备方法
CA2943746C (en) * 2014-04-28 2023-08-15 Philip Morris Products S.A. Flavoured nicotine powder inhaler

Also Published As

Publication number Publication date
UA126853C2 (uk) 2023-02-15
RU2018144108A (ru) 2020-07-30
US11458093B2 (en) 2022-10-04
AU2017290610A1 (en) 2018-11-15
CN109310623A (zh) 2019-02-05
EP3478265A1 (en) 2019-05-08
MX2018015119A (es) 2019-04-15
US20190117567A1 (en) 2019-04-25
RU2741309C2 (ru) 2021-01-25
CN109310623B (zh) 2022-10-21
ZA201807080B (en) 2019-07-31
SG11201809630RA (en) 2018-11-29
US20230000767A1 (en) 2023-01-05
JP2019519542A (ja) 2019-07-11
IL263340A (en) 2018-12-31
JP7471774B2 (ja) 2024-04-22
PH12018502715A1 (en) 2019-07-29
RU2018144108A3 (pt) 2020-07-30
CA3023626A1 (en) 2018-01-04
JP2022116082A (ja) 2022-08-09
KR20190026655A (ko) 2019-03-13
KR102559152B1 (ko) 2023-07-26
WO2018002779A1 (en) 2018-01-04

Similar Documents

Publication Publication Date Title
BR112018075017A2 (pt) partículas de nicotina
DOP2017000298A (es) Reguladores de nrf2
CL2018003323A1 (es) Piridinas sustituidas con heteroarilo y métodos de uso.
CL2018001478A1 (es) Agonistas del receptor de apelina y métodos de uso
EA201891083A1 (ru) Составы антител к cd38 для подкожного введения и их применение
CO2018002598A2 (es) Compuestos para modular la expresión de angiotensinógeno, composiciones que los contienen y procesos para su producción
CL2015002865A1 (es) Composiciones de limpieza que contienen una poliéteramina
EA201691259A1 (ru) РЕГУЛЯТОРЫ Nrf2
CL2020000422A1 (es) Composiciones de glp-1 y sus usos.
ECSP16061758A (es) Moduladores de tetrahidropiridopirazinas de gpr6
UY37169A (es) Análogos de 1,4-dihidropirimidin-5-carboxamidas como agonistas de apj y composiciones que los contienen
UY36949A (es) 2,4-dihidroxi-nicotinamidas como agonistas de apj
BR112017027137A2 (pt) reguladores de nrf2
EA201691945A1 (ru) Антитела к гемагглютинину вируса гриппа типа b и способы их применения
EA201591728A1 (ru) Гетероциклические соединения и способы их применения
EA201790896A1 (ru) Пролекарства фенольных агонистов trpv1
EA201892509A1 (ru) Антитела к гемагглютинину и способы применения
DOP2018000062A (es) Piridinona dicaboxamidas para uso como inhibidores de bromodominio
CL2016003074A1 (es) Compuestos derivados de 2-oxi-2-fenil-n-5-pirrolidin-3-ilamino-1,3,4-tiadiazol-2-ilacetamida, inhibidores gls1 composición farmacéutica y su uso para tratar el cáncer.
ECSP18018793A (es) Compuestos útiles para inhibir ror-gamma-t
BR112017018172B8 (pt) Método para romper um biofilme através de composições compreendendo combinações de ácidos orgânicos
CR20170090A (es) Derivados de terahidroquinolina como inhibidores del bromodominio
BR112018009627A2 (pt) compostos contendo enxofre como solventes
EA201992168A1 (ru) Аналоги деутетрабеназина, их получение и применение
EA201791437A1 (ru) Композиции микросфер c инкапсулированным в липиде газом и соответствующие способы

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]